|
Sign In to gain access to subscriptions and/or personal tools.
|
Angiotensin type 2 receptor is expressed in human atherosclerotic lesions
Maria E Johansson
Department of Molecular and Clinical Medicine/Clinical Physiology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
Björn Fagerberg
The Wallenberg Laboratory for Cardiovascular Research, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
Göran Bergström
Department of Molecular and Clinical Medicine/Clinical Physiology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden, goran.bergstrom{at}hjl.gu.se
Objective. Expression of the angiotensin type 2 receptor (AT2-receptor) occurs in many animal models of atherosclerosis. However, its expression in human plaques and its functional role remains undetermined.This study examined AT2-receptor expression in human atherosclerotic plaque and also explored its potentially important functional role in atherosclerosis.
Material and methods. We analysed carotid atherosclerotic plaques obtained from 14 Caucasian patients who had previously carotid artery stenosis. Half of all subjects undergone endarterectomy for symptomatic carotid artery stenosis. Half of all subjects received treatment with an angiotensin receptor blocker (ARB) (n=7); the remaining subjects received no intervention in the renin-angiotensin system (n=7). Immunohistochemistry measured tissue expression of smooth muscle cells ( -actin), macrophages (CD68 antibody), collagen (picro-sirius), and AT2-receptor (AT2-receptor antibody).
Results. AT2-receptor expression occurred consistently in all specimens. Although cellular localisation varied, AT2-receptor expression levels correlated with macrophage levels (p<0.01). Compared to conventional treatment, ongoing ARB treatment affected neither AT2-receptor levels nor plaque composition.
Conclusions. AT2-receptor is expressed in human atherosclerotic plaque. Furthermore, we detected no functionally important role of AT2-receptor expression and found no evidence that ARB treatment regulates AT2-receptor expression.
Key Words: angiotensin II angiotensin receptor blocker angiotensin type 2 receptor atherosclerosis human carotid plaques
References
- Brasier AR, Recinos A., 3rd, Eledrisi MS Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002;22:1257-66.[Abstract/Free Full Text]
- Mazzolai L., Hayoz D. The renin-angiotensin system and atherosclerosis. Curr Hypertens Rep 2006;8(1):47-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Daugherty A., Rateri DL, Lu H., Inagami T., Cassis LA Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004;110:3849-57.[Abstract/Free Full Text]
- Unger T. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens 1999;17:1775-86.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Steckelings UM, Kaschina E., Unger T. The AT2 receptor-a matter of love and hate. Peptides 2005; 26:1401-09.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Widdop RE, Jones ES, Hannan RE, Gaspari TA Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 2003;140:809-24.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Johansson ME, Wickman A., Fitzgerald SM, Gan LM, Bergstrom G. Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE-/- mice. J Hypertens 2005;23:1541-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Johansson ME, Wickman A., Skøtt O., Gan LM, Bergström G. Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE-/- mice. J Hypertens 2006;24:2001-08.[Web of Science][Medline]
[Order article via Infotrieve]
- Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P., Dzau VJ, Pratt RE Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 200;112:3328-36.
- Savoia C., Touyz RM, Volpe M., Schiffrin EL Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007;49:341-6.[Abstract/Free Full Text]
- Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-74.[Abstract/Free Full Text]
- Zulli A., Burrell LM, Widdop RE, Black MJ, Buxton BF, Hare DL Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J Histochem Cytochem 2006;54:147-50.[Abstract/Free Full Text]
- Horiuchi M., Hayashida W., Akishita M. et al. Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1. Circ Res 2000;86:233-40.[Abstract/Free Full Text]
- Akishita M., Horiuchi M., Yamada H. et al. Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics 2000;2(1):13-20.[Abstract/Free Full Text]
- Daugherty A., Manning MW, Cassis LA Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001;134:865-70.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gohlke P., Pees C., Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998;31:349-55.[Abstract/Free Full Text]
- Rubio AR, Morales-Segura MA Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res 2004;35(1):1-11.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Volpe M., Musumeci B., De Paolis P., Savoia C., Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 2003;21:1429-43.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cipollone F., Fazia ML, Mezzetti A. Role of angiotensin II receptor blockers in atherosclerotic plaque stability. Expert Opin Pharmacother 2006;7:277-85.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Okamura A., Rakugi H., Ohishi M. et al. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens 1999;17:537-45.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cipollone F., Fazia M., Iezzi A. et al. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 2004; 109:1482-8.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 9, No. 1,
17-21 (2008)
DOI: 10.3317/jraas.2008.005

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Schindler
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET
Therapeutic Advances in Cardiovascular Disease,
August 1, 2008;
2(4):
233 - 248.
[Abstract]
[PDF]
|
 |
|
|
|